Home/Filings/4/0001181431-11-058627
4//SEC Filing

Davis Glenn Eugene 4

Accession 0001181431-11-058627

CIK 0000930553other

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 8:34 PM ET

Size

7.5 KB

Accession

0001181431-11-058627

Insider Transaction Report

Form 4
Period: 2011-11-30
Davis Glenn Eugene
VP Legal & Chief Comp. Officer
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2011-11-30$3.75/sh+33,750$126,56333,750 total
    Exercise: $3.75From: 2013-11-30Exp: 2021-11-30Common Stock (33,750 underlying)
  • Award

    Common Stock

    2011-11-30$0.00/sh+7,500$829,833 total
Footnotes (2)
  • [F1]One-half (1/2) of the Shares subject to the Award shall vest on the second anniversary after the date of grant and one-half (1/2) of the Shares subject to the Award shall vest on the fourth anniversary after the date of grant so that the Award shall be fully vested on the fourth anniversary after the date of grant, subject to the Optionee continuing to be a Service Provider on such dates.
  • [F2]One-half (1/2) of the Shares subject to the Option shall vest on the second anniversary after the date of grant one one-half (1/2) of the Shares subject to the Option shall vest on the fourth anniversary after the date of grant so that the Option shall be fully vested on the fourth anniversary after the date of grant, subject to the Optionee continuing to be a Service Provider on such dates.

Issuer

ISTA PHARMACEUTICALS INC

CIK 0000930553

Entity typeother

Related Parties

1
  • filerCIK 0001507370

Filing Metadata

Form type
4
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 8:34 PM ET
Size
7.5 KB